Peter Harris

115 Flips | 1 Magazine | 11 Likes | 6 Followers | @PeterHarrisHRB | Improving human health through life science robotics

Scientists in China Race to Edit Crop Genes, Sowing Unease in U.S.

Chinese-owned Syngenta makes strides in new technologies to alter plant DNA, as U.S. farmers worry that cutting-edge agricultural science is shifting East<p>China is seeking a lead in editing plant genes, potentially shifting the epicenter of the emerging agricultural technology toward the …

Genetics

Unum Therapeutics Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX) (“Unum Therapeutics”), a clinical-stage biopharmaceutical …

CAR-T Companies: The Meteoric Rise Of Cellular Immunotherapies

CAR-T companies are on the rise, supported by growing investment flowing into CAR-T research, landmark approvals of CAR-T cell therapies by the U.S. …

Breakthrough enables screening millions of human antibodies for new drug discovery

A paper just published in Nature Biotechnology outlines a pioneering method of screening a person's diverse set of antibodies for rapid therapeutic …

Academic Research

Made in China: New and Potentially Lifesaving Drugs

SHANGHAI — One new drug promises to stop cancer from spreading to other organs. Another would treat blood cancer. A third would use the body’s immune system to kill tumors.<p>All three show encouraging results, and need just one more step to be approved for use in the United States. The drugs have …

China

Investors Launch Biotech Startup Jnana Therapeutics With $50 Million

Company takes aim at proteins known as SLC transporters to treat variety of diseases<p>Investors are betting that protein science will lead to new lines of attack on disease.<p>Jnana Therapeutics Inc. is launching with $50 million and a plan to discover drugs for cancer and other conditions by zeroing in …

Biotechnology

"Mind-blowing results" from gene therapy trial point to a cure for haemophilia

The results from the first human trials for a gene therapy to treat patients with haemophilia A have just been published, and they are truly …

69 Startups Using Artificial Intelligence in Drug Discovery

Describes startups using artificial intelligence in drug discovery, from identifying candidates, to conducting clinical trials, to publishing data.

Bitter CRISPR patent war intensifies

Gene-editing pioneers prepare for next stage of intellectual-property disputes in the United States and Europe.<p>The long-running battle over US …

F.D.A. Approves Second Gene-Altering Treatment for Cancer

The Food and Drug Administration on Wednesday approved the second in a radically new class of treatments that genetically reboot a patient’s own immune cells to kill cancer.<p>The new therapy, Yescarta, made by Kite Pharma, was approved for adults with aggressive forms of a blood cancer, non-Hodgkin’s …

Cancer

Drug Discovery World Fall17

New breakthrough allows machines to literally predict the behavior of molecules

Simplifying the Complex<p>Though much noise has been made of what’s still to come from artificial intelligence (AI), the technology has already changed …

Researchers find "executioner protein" that causes cancer cells to self-destruct without hurting healthy cells

Killing Cancer with Apoptosis<p>Albert Einstein College of Medicine scientists have induced cancer cells to commit suicide with a new compound that …

Drug discovery startup Recursion raises $60 million in Series B from Data Collective

Recursion, a drug discovery startup out of Salt Lake City, Utah has announced a $60 million Series B round, led by Data Collective (DCVC).<p>Recursion started out in 2014 on a mission to identify 100 new treatments in 10 years. That’s a lofty goal, considering the discovery for just one drug can …

Venture Capital

Screening Technologies for Small Molecule Discovery: The State of the Art

Screening, high-throughput screening, and ultra-high-throughput screening are all really just points on a spectrum that represent differing …

Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy

Investors have been waiting for years for Gilead Sciences to make another big splash. This morning, it finally did, agreeing to buy Kite Pharma for …

Biotechnology

AstraZeneca taps AI for drug discovery in deal with Berg

LONDON (Reuters) - AstraZeneca (AZN.L) has forged a research collaboration with Boston-based Berg, a specialist in artificial intelligence for drug hunting, in the latest sign of big pharma's interest in using supercomputers for drug discovery.<p>The tie-up will focus on finding and evaluating novel …

Artificial Intelligence

Cargill Invests in Startup That Grows ‘Clean Meat’ From Cells

Memphis Meats says Cargill’s interest follows funding from Bill Gates, Richard Branson and others<p>Cargill Inc. is betting you won’t always need cattle to make hamburgers.<p>The agricultural conglomerate has invested in Memphis Meats Inc., a startup developing technology to grow meat from …

Bill Gates

UNITY Biotechnology Announces Series B Financing Extension Bringing Total Round to $151 Million

UNITY Biotechnology, a privately held biotechnology company creating therapeutics that prevent, halt, or reverse numerous diseases of aging, …

Meet Eva, the workplace robot that won’t necessarily steal your job

The technology industry likes to talk about how automation is set to change the world. Chatbots present a new way of interacting with software, self-driving cars promise to reshape our cities, and the increasing capability of AI to handle ever more complex and “human” tasks could reshape our …

Robotics

How AI Robots Hunt New Drugs For Crippling Nerve Disease

ALS attacks and kills nerve cells controlling muscles, leading to weakness, paralysis and, ultimately, respiratory failure.<p>LONDON (Reuters) - Artificial intelligence robots are turbo-charging the race to find new drugs for the crippling nerve disorder ALS, or motor neurone disease.<p>The condition, …

Artificial Intelligence

UVA Health System Enlists Robotic Help to Enhance Blood Testing

The University of Virginia Health System has revolutionized how it tests patient blood samples, automating its primary testing facility with …

Blood Tests

Is big pharma really on cusp of AI shake-out?

<b>Artificial intelligence could herald a new era for drug development but caution remains about how revolutionary its impact will actually …

TB drug discovery paves way to pharmaceutical superhighway | Cosmos

The hunt for new drugs often involves checking and rechecking thousands of already identified compounds. If a compound interacts promisingly with the …

Nature Communications

DNA sequencing and big data open a new frontier in the hunt for new viruses

Discovering new viruses has historically been biased towards people and animals that exhibit symptoms of disease – like a cough, fever or skin …

Artificial Intelligence In Drug Discovery: A Bubble Or A Revolutionary Transformation?

Artificial intelligence (AI) has become a hot topic in the area of life sciences lately. With a growing number of groundbreaking AI use cases in other hi-tech industries — ranging from self-driving cars to speech and image recognition tools to personal assistants (you know Siri, don’t you?) — …

Artificial Intelligence

A Robot Can Be a Warehouse Worker’s Best Friend

Companies are racing to develop ‘collaborative’ robots, which are relatively cheap and can boost employees’ productivity<p>By<p>Jennifer Smith<p>Jennifer Smith<p>The Wall Street Journal<p>Biography<p>@jensmithWSJ<p>Google+<p>Jennifer.Smith@wsj.com<p>In the battle of humans versus machine on the warehouse floor, some …

Robotics

In Breakthrough, Scientists Edit a Dangerous Mutation From Genes in Human Embryos

Scientists for the first time have successfully edited genes in human embryos to repair a common and serious disease-causing mutation, producing apparently healthy embryos, according to a study published on Wednesday.<p>The research marks a major milestone and, while a long way from clinical use, it …

Genetics

Kite first to submit CAR-T therapy in Europe

Kite Pharma has submitted the first CAR-T cell therapy in Europe, seeking permission to market its axicabtagene ciloleucel (axi-cel) to treat …

Biotechnology